Get started
Author

Kirsten G. M. Aspros

Observed names: K Aspros, Kirsten Aspros, Kirsten G.M. Aspros, Kirsten GM Aspros
Institution: Mayo Clinic
Observed institution: Mayo Clinic
ORCID: 0000-0001-9643-2139
Observed ORCID: 0000-0001-9643-2139
OpenAlex ID: A5084483177
Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues
2019 · John R. Hawse, Jodi M. Carter, et al. · Breast Cancer Research and Treatment · 38
Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer
2022 · Kirsten G. M. Aspros, Jodi M. Carter, et al. · npj Breast Cancer · 19
PDF
Estrogen-regulated miRs in bone enhance osteoblast differentiation and matrix mineralization
2023 · Michael J. Emch, Zofia Wicik, et al. · Molecular Therapy — Nucleic Acids · 7
PDF
Disruption of estrogen receptor beta’s DNA binding domain impairs its tumor suppressive effects in triple negative breast cancer
2023 · Kirsten G. M. Aspros, Michael J. Emch, et al. · Frontiers in Medicine · 6
PDF
SUN-LB135 Estrogen Receptor Beta Inhibits NFkB Signaling to Inhibit Triple Negative Breast Cancer
2020 · Kirsten Aspros, Malayannan Subramaniam, et al. · Journal of the Endocrine Society · 3
PDF
Abstract P4-02-09: The lncRNA XIST mediates sensitivity to ERβ targeted therapies in triple negative breast cancer
2022 · Michael J Emch, Kirsten GM Aspros, et al. · Cancer Research · 2
Abstract P5-05-03: Estrogen receptor beta elicits anti-cancer effects in triple negative breast cancer through suppression of NFκB signaling
2019 · K Aspros, A Nelson, et al. · Cancer Research · 1
Abstract 2293: The LncRNA XIST mediates resistance to estrogen receptor beta targeted therapies in triple negative breast cancer
2026 · Michael Emch, Kirsten Aspros, et al. · Cancer Research
Abstract P6-05-02: Estrogen receptor beta repurposes EZH2 to inhibit oncogenic NFκB signaling in triple negative breast cancer
2020 · Kirsten GM Aspros, Adam W Nelson, et al. · Cancer Research
Works count: 9
Citation count: 76
H-index: 4
I10-index: 2
Year
Topic
Type